← Leaderboards
Ji Miao
Boston Children'S Hospital
$5,049,245
Attributed
$5,049,245
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $935.7K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,049,245 · 4
By mechanism
R01$4,122,245 · 2
R00$747,000 · 1
K99$180,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Zhigang He$31,904,301
Others in their field
Top investigators on “Regulation”
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
- David Heimbrook · Leidos Biomedical Research, Inc.$152,164,826
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Nevan J Krogan · University Of California, San Francisco$101,337,442
- Asimah Rafi · Technical Resources Inc$95,881,052
- Richard C Boucher · University Of North Carolina Chapel Hill$83,460,414
Research focus
RegulationHepatocyteMetabolicCardiovascular DiseasesHepaticLiverObesityKnock-OutGene ExpressionGenesLipid MetabolismInsulin ResistanceHigh Fat DietPromoterBlood Glucose RegulationKnockout MiceMolecularNon-Alcoholic Fatty Liver DiseaseFeedingHomeostasisHypertriglyceridemiaBindingInsightDiabetes Mellitus
Grant awards (14)
Copper and copper-binding proteins in insulin resistance-associated metabolic disease$484,274
R01 · FY2025 · DK · contact PI
Role of TAZ in metabolic regulation in both normal and insulin resistant states$406,311
R01 · FY2025 · DK · contact PI
Copper and copper-binding proteins in insulin resistance-associated metabolic disease$464,904
R01 · FY2024 · DK · contact PI
Role of TAZ in metabolic regulation in both normal and insulin resistant states$433,398
R01 · FY2024 · DK · contact PI
Copper and copper-binding proteins in insulin resistance-associated metabolic disease$484,274
R01 · FY2023 · DK · contact PI
Role of TAZ in metabolic regulation in both normal and insulin resistant states$451,456
R01 · FY2023 · DK · contact PI
Copper and copper-binding proteins in insulin resistance-associated metabolic disease$484,276
R01 · FY2022 · DK · contact PI
Role of TAZ in metabolic regulation in both normal and insulin resistant states$451,456
R01 · FY2022 · DK · contact PI
Role of TAZ in metabolic regulation in both normal and insulin resistant states$461,896
R01 · FY2021 · DK · contact PI
Insulin Regulation of Liver X Receptor in Normal and Insulin Resistant States$249,000
R00 · FY2018 · DK · contact PI
Insulin Regulation of Liver X Receptor in Normal and Insulin Resistant States$249,000
R00 · FY2017 · DK · contact PI
Insulin Regulation of Liver X Receptor in Normal and Insulin Resistant States$249,000
R00 · FY2016 · DK · contact PI
Insulin Regulation of Liver X Receptor in Normal and Insulin Resistant States$90,000
K99 · FY2014 · DK · contact PI
Insulin Regulation of Liver X Receptor in Normal and Insulin Resistant States$90,000
K99 · FY2013 · DK · contact PI